Cargando…
Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a virus called “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).” In the majority of patients, infection with COVID-19 may be asymptomatic or may cause only mild symptoms. However, in some patients, there can also be...
Autores principales: | Gupta, Anita, Gupta, G. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981598/ https://www.ncbi.nlm.nih.gov/pubmed/33745077 http://dx.doi.org/10.1007/s11010-021-04107-3 |
Ejemplares similares
-
Mannose-binding lectin (MBL) and the lectin complement pathway play a role in cutaneous ischemia and reperfusion injury
por: Peck, Claas-Tido, et al.
Publicado: (2020) -
The ambiguous role of mannose-binding lectin (MBL) in human immunity
por: Kalia, Namarta, et al.
Publicado: (2021) -
Mannose-binding lectin (MBL) levels in children with Hashimoto’s thyroiditis
por: Gul, Ali, et al.
Publicado: (2023) -
Are mannose-binding lectin gene 2 (MBL2) polymorphisms and MBL deficiency associated with infections?
por: Pradhan, Vandana, et al.
Publicado: (2011) -
Fasciola hepatica is refractory to complement killing by preventing attachment of mannose binding lectin (MBL) and inhibiting MBL-associated serine proteases (MASPs) with serpins
por: De Marco Verissimo, Carolina, et al.
Publicado: (2022)